Klaus Kühlcke
BioNTech (Germany)(DE)
Publications by Year
Research Areas
Virus-based gene therapy research, CAR-T cell therapy research, CRISPR and Genetic Engineering, RNA Interference and Gene Delivery, Viral Infectious Diseases and Gene Expression in Insects
Most-Cited Works
- → Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1(2006)1,183 cited
- → Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease(2010)775 cited
- → Murine Leukemia Induced by Retroviral Gene Marking(2002)654 cited
- → Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity(2014)543 cited
- → Stem-Cell Gene Therapy for the Wiskott–Aldrich Syndrome(2010)532 cited
- → An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors(2020)490 cited
- → Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor(2014)338 cited
- → Fibroblasts as Efficient Antigen-Presenting Cells in Lymphoid Organs(1995)306 cited
- → CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial(2023)236 cited
- → Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population(2003)187 cited